Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Immix Biopharma, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 11 | 1 | 8 | −2 |
| Shares | 1.54M | 20.0K | 146.5K | −1.37M (−90.4%) |
| Value | $5.47M | $71.2K | $352.0K | −$5.05M (−93.5%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Immix Biopharma, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 62,600 | $151.0K | 0.00% |
| Virtu Financial LLC | 23,515 | $57.0K | 0.00% |
| InterOcean Capital Group, LLC | 15,900 | $38.0K | 0.00% |
| XTX Topco Ltd | 12,992 | $31.0K | 0.01% |
| BlackRock Inc. | 9,415 | $22.0K | 0.00% |
| Advisor Group Holdings, Inc. | 350 | $1.00K | 0.00% |
| Wells Fargo & Company | 26 | $0 | 0.00% |
Sold out (9)
Institutions that held Immix Biopharma, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Murchinson Ltd. | 695,600 | $2.48M |
| Lynwood Capital Management Inc. | 565,297 | $2.01M |
| Altium Capital Management LP | 122,388 | $436.0K |
| UBS Group AG | 32,649 | $116.0K |
| Eidelman Virant Capital | 29,856 | $103.0K |
| Millennium Management LLC | 20,470 | $73.0K |
| Two Sigma Securities, LLC | 13,173 | $47.0K |
| Context Capital Management, LLC | 11,532 | $41.0K |
| Clear Street LLC | 1,000 | $4.00K |
Not filed for Q1 2022 yet (1)
Institutions that held Immix Biopharma, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| PVG Asset Management Corp | 20,000 | $71.2K |